Relationship between the peripheral arterial occlusive disease and the infection by Chlamydophila pneumoniae;Relación entre la enfermedad arterial periférica oclusiva y la infección por Chlamydophila pneumoniae

Medicina Clinica

Volumn 123, Issue 15, 2004, Pages 561-566

  Gutiérrez, José ^a,e   Linares, José ^a,b   Fernández, Fernando ^a   Ros, Eduardo ^a,b   De Dios Luna, Juan ^a   Mendoza, Joaquín ^c   Soto, María José ^a   López, Cristina ^d   Maroto, Carmen ^a,b  

^a UNIVERSITY OF GRANADA   (Spain)

^b HOSPITAL UNIVERSITARIO SAN CECILIO   (Spain)

^c VIRCELL S L   (Spain)

^d HOSPITAL UNIVERSITARIO VIRGEN DE LAS NIEVES   (Spain)

^e UNIVERSITY OF GRANADA   (Spain)

Author keywords

Atherosclerosis; Chlamydophila pneumoniae; Peripheral arterial occlusive disease

Indexed keywords

BACTERIAL ANTIGEN; BACTERIAL DNA; IMMUNOGLOBULIN A ANTIBODY; IMMUNOGLOBULIN G ANTIBODY; LIPOPOLYSACCHARIDE;

ADULT; AGED; ANTIBODY DETECTION; ANTIGEN PURIFICATION; ARTICLE; ATHEROSCLEROTIC PLAQUE; BACTERIAL INFECTION; BACTERIAL STRAIN; BACTERIUM CULTURE; BLOOD VESSEL BIOPSY; CELL CULTURE; CHLAMYDOPHILA PNEUMONIAE; CONTROLLED STUDY; DNA DETERMINATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; LEUKOCYTE; MAJOR CLINICAL STUDY; MALE; PERIPHERAL OCCLUSIVE ARTERY DISEASE;

EID: 9944225652     PISSN: 00257753     EISSN: None     Source Type: Journal    
DOI: 10.1157/13067999     Document Type: Article

References (55)

1. Campbell LA, Kuo CC. Chlamydia pneumoniae and atherosclerosis. Semin Respir Infect 2003;18:48-54.
2. Monno R, De Vito D, Losito G, Sibilio G, Costi A, Fumarola L, et al. Chlamydia pneumoniae in community-acquired pneumonia: seven years of experience. J Infect 2002;45:135-8.
3. Moazed TC, Kuo CC, Grayston JT, Campbell LA. Evidence for systemic dissemination of Chlamydia pneumoniae via macrophages in the mouse. J Infect Dis 1998;177:1322-5.
4. Linnanmaki E, Leinonen M, Mattila K, Nieminen MS, Valtonen V, Saikku P. Chlamydia pneumoniae-specific circulating immune complexes in patients with chronic coronary heart disease. Circulation 1993;87:1130-4.
5. Saikku P, Leinonen M, Mattila K, Ekman MR, Nieminen MS, Makela PH, et al. Serological evidence of an association of a novel chlamydia, TWAR, with chronic coronary heart disease and acute myocardial infarction. Lancet 1988;2:983-6.
6. Tiran A, Tio RA, Ossewaarde JM, Tiran B, Den Heijer P, The TH, et al. Coronary angioplasty induces rise in Chlamydia pneumoniae-specific antibodies. J Clin Microbiol 1999;37:1013-7.
7. Anderson JL, Carlquist JF, Muhlestein JB, Horne BD, Elmer SP. Evaluation of C-reactive protein, an inflammatory marker, and infectious serology as risk factors for coronary artery disease and myocardial infarction. J Am Coll Cardiol 1998;32:35-41.
8. Gerdes VE, Verkooyen RP, Kwa VI, De Groot E, Van Gorp EC, Ten Cate H, et al. Chlamydial LPS antibodies, intima-media thickness and ischemic events in patients with established atherosclerosis. Atherosclerosis 2003;167:65-71.
9. Weiss SM, Roblin PM, Gaydos CA, Cummings P, Patton DL, Schulhoff N, et al. Failure to detect Chlamydia pneumoniae in coronary atheromas of patients undergoing atherectomy. J Infect Dis 1996;173:957-62.
10. Bishara J, Pitlik S, Kazakov A, Sahar G, Haddad M, Vojdani A, et al. Failure to detect Chlamydia pneumoniae by cell culture and polymerase chain reaction in major arteries of 93 patients with atherosclerosis. Eur J Clin Microbiol Infect Dis 2003;22:300-2.
11. Bishara J, Pitlik S, Kazakov A, Sahar G, Haddad M, Vojdani A, et al. Failure to demostrate Chlamydia pneumoniae in symptomatic abdominal aortic aneurysms by a nested polymerase chain reaction (PCR). Eur J Vasc Endovasc Surg 1998;15:161-4.
12. Ong GM, Coyle PV, Barras D'Sa AA, McCluggage WG, Duprex WP, O'Neill HJ, et al. Non-detection of Chlamydia species in carotid atheroma using generic primers by nested PCR in a population with a high prevalence of Chlamydia pneumoniae antibody. BMC Infect Dis 2001;1:12.
13. Blasi F, Boman J, Esposito G, Melissano G, Chiesa R, Cosentini R, et al. Chlamydia pneumoniae DNA detection in peripheral blood mononuclear cells is predictive of vascular infection. J Infect Dis 1999;180:2074-6.
14. Gutiérrez J, Linares JP, Rodríguez M, Maroto MC. Chlamydia pneumoniae y su relacion con la arteriosclerosis humana. Rev Invest Clin 2000;52:482-6.
15. Muhlestein JB, Anderson JL, Hammond EH, Zhao L, Trehan S, Schwobe EP, et al. Infection with Chlamydia pneumoniae accelerates the development of atherosclerosis and treatment with azithromycin prevents it in a rabbit model. Circulation 1998;97:633-66.
16. Dunne M, WIZARD and the design of trials for secondary prevention of atherosclerosis with antibiotics. Am Heart J 1999;138:542-4.
17. Jackson LA. Description and status of the azithromycin and coronary events study (ACES). J Infect Dis 2000;181:579-81.
18. Muhlestein JB, Anderson JL, Carlquist JF, Salunkhe K, Horne BD, Pearson RR, et al. Randomized secondary prevention trial of azithromycin in patients with coronary artery disease: primary clinical results of the ACADEMIC study. Circulation 2000;102:1755-60.
19. Labs KH, Dormandy JA, Jaeger KA, Stuerzebecher CS, Hiatt WR. Transatlantic conference on clinical trial guidelines in peripheral arterial disease. Circulation 1999;100:75-81.
20. Bennedsen M, Berthelsen L, Lind I. Performance of three microimmunofluorescence assays for detection of Chlamydia peumoniae immunoglobulin M, G, and A antibodies. Infection, atherosclerosis and macrolide antibiotics group. Clin Diagn Lab Immunol 2002;9:833-9.
21. Gutiérrez J, Mendoza J, Fernández F, Linares-Palomino J, Soto MJ, Maroto MC. ELISA test to detect Chlamydophila pneumoniae IgG. J Basic Microbiol 2002;42:13-8.
22. Gutiérrez J, Linares J, López C, Rodríguez M, Ros E, Piédrola G, et al. Chlamydia pneumoniae DNA in the arterial wall of patients with peripheral vascular diseases (PAOD). Infection 2001;29:196-200.
23. Campbell LA, Pérez Melgosa M, Hamilton DJ, Kuo CC, Grayston JT. Detection of C. pneumoniae by polymerase chain reaction. J Clin Microbiol 1992;30:434-9.
24. Kwok S, Higuchi R. Avoiding false positives with PCR. Nature 1989;339:237-8.
25. Gutiérrez J, Maroto MC, Piédrola G. Granulocyte abnormalities in parenteral drug addicts. The influence of HIV infection. Allergol Immunopathol 1989;17:251-5.
26. Dean D, Ferrero D, Mc Carthy M. Comparison of performance and cost-effectiveness of direct fluorescent-antibody, ligase chain reaction, and PCR assays for verification of chlamydial enzyme immunoassay result for populations with a low moderate prevalence of Chlamydia trachomatis infection. J Clin Microbiol 1998;36:94-9.
27. Maass M, Harig U. Evaluation of culture conditions used for isolation of Chlamydia pneumoniae. Am J Clin Pathol 1995;103:141-8.
28. Hahn DL, Golubjatnikov R. Smoking is a potential confounder of the C. pneumoniae coronary artery disease association. Arterioscl Thromb 1992;12:945-7.
29. Ramos PM, Ortega F, Samaniego J, Díaz R. Microscopía electrónica, Chlamydia pneumoniae y arteriosclerosis. Med Clin (Barc) 1999;27:277-8.
30. Blanchard JF, Armenian HK, Peeling R, Friesen PP, Shen C, Brunham RC. The relation between Chlamydia pneumoniae infection and abdominal aortic aneurysm: case-control study. Clin Infect Dis 2000;30:946-7.
31. Melnick SL, Shahar E, Folsom AR, Grayston JT, Sorlie PD, Wang SP, et al. Past infection by Chlamydia pneumoniae strain TWAR and asymptomatic carotid atherosclerosis. Atherosclerosis Risk in Communities (ARIC) Study Investigators. Am J Med 1993;95:499-504.
32. Elkind MS, Lin IF, Grayston JT, Sacco RL. Chlamydia pneumoniae and the risk of first ischemic stroke: The Northern Manhattan Stroke Study. Stroke 2000;31:1521-5.
33. Porqueddu M, Spirito R, Parolari A, Zanobini M, Pompilio G, Polvani G, et al. Lack of association between serum immunoreactivity and Chlamydia pneumoniae detection in the human aortic wall. Circulation 2002;106:2647-8.
34. Geisler WM, Suchland RJ, Rockey DD, Stamm WE. Epidemiology and clinical manifestations of unique Chlamydia trachomatis isolates that occupy nonfusogenic inclusions. J Infect Dis 2001;184:879-84.
35. Veerkoyen RP. Chlamydia pneumoniae - studies on an emerging pathogen [tesis doctoral]. Rotterdam: University of Rotterdam, 1997
36. Smieja M, Mahony J, Petrich A, Boman J, Chernesky M. Association of circulating Chlamydia pneumoniae DNA with cardiovascular disease: a systematic review. BMC Infect Dis 2002;2:21.
37. Sessa R, Di Pietro M, Schiavoni G, Santino I, Cipriani P, Romano S, et al. Prevalence of Chlamydia pneumoniae in peripheral blood mononuclear cells in Italian patients with acute ischaemic heart disease. Atherosclerosis 2001; 159:521-5.
38. Mendall MA, Carrington D, Strachan D, Patel P, Molineaux N, Levi J, et al. C. pneumoniae: risk factors for seropositivity and association with coronary heart disease. J Infect 1995;30:121-8.
39. Karunakaran K, Blanchard J, Raudonikiene A, Shen C, Murdin AD, Brunham RC. Molecular detection and seroepidemiology of the Chlamydia pneumoniae bacteriophage (PhiCpn1). J Clin Microbiol 2002;40:4010-4.
40. Mazzoli S, Tofani N, Fantini A, Semplici F, Bandini F, Salvi A, et al. Chlamydia pneumoniae antibody response in patients with acute myocardial infarction and their follow-up. Am Heart J 1998;135:15-20.
41. Emre U, Roblin PM, Gelling M, Dumornay W, Rao M, Hammerschlag MR, et al. The association of Chlamydia pneumoniae and reactive airway disease in children. Arch Pediatr Adolesc Med 1994;148:727-32.
42. Maurin M, Eb F, Etienne J, Raoult D. Serological cross-reaction between Bartonella and Chlamydia species implications for diagnosis. J Clin Microbiol 1997;35:2283-7.
43. Markus HS, Sitzer M, Carrington D, Mendall MA, Steinmetz H. Chlamydia pneumoniae infection and early asymptomatic carotid atherosclerosis. Circulation 1999;100:832-7.
44. Toss H, Gnarpe J, Gnarpe H, Siegbahn A, Lindahl B, Wallentin L. Increased fibrinogen levels are associated with persistent Chlamydia pneumoniae infection in unstable coronary artery disease. Eur Heart J 1998;19:570-7.
45. Petersen E, Boman J, Persson K, Arnerlov C, Wadell G, Juto P, et al. Chlamydia pneumoniae in human abdominal aortic aneurysms. Eur J Vasc Endovasc Surg 1998;15:138-42.
46. Maass M, Krause E, Engel PM, Kruger S. Endovascular presence of Chlamydia pneumoniae in patients with hemodynamically effective carotid artery stenosis. Angiology 1997;48:699-706.
47. Karlsson L, Gnarpe J, Naas J, Olsson G, Lindholm J, Steen B, et al. Detection of viable Chlamydia pneumoniae in abdominal aortic aneurysms. Eur J Vasc Endovasc Surg 2000;19:630-5.
48. Dobrilovic N, Vadlamani L, Meyer M, Wright CB. Chlamydia pneumoniae in atherosclerotic carotid artery plaques: high prevalence among heavy smokers. Am Surg 2001;67:589-93.
49. Ong G, Thomas BJ, Mansfield AO, Davidson BR, Taylor-Robinson D. Detection and widespread distribution of Chlamydia pneumoniae in the vascular system and its possible implications. J Clin Pathol 1996;49:102-6.
50. Nieto FJ, Folsom AR, Sorlie PD, Grayston JT, Wang SP, Chambless LE. Chlamydia pneumoniae infection and incident coronary heart disease: the Atherosclerosis Risk in Communities Study. Am J Epidemiol 1999;150:149-56.
51. Ciuffetti G, Mannarino E, Paltriccia R, Malagigi V, Sergi F, Paulisch P. Leukocyte activity in chronic venous insufficiency. Int Angiol 1994;13: 312-6.
52. Boman J, Gaydos CA. Polymerase chain reaction detection of Chlamydia pneumoniae in circulating white blood cells. J Infect Dis 2000;181:452-4.
53. Smieja M, Mahony JB, Goldsmith CH, Chong S, Petrich A, Chernesky M. Replicate PCR testing and probit analysis for detection and quantitation of Chlamydia pneumoniae in clinical specimens. J Clin Microbiol 2001;39:1796-801.
54. Apfalter P, Loidl M, Nadrchal R, Makristathis A, Rotter M, Bergmann M, et al. Isolation and continuous growth of C. pneumoniae from arterectomy specimens. Eur J Clin Microbiol Infect Dis 2000;19:305-8.
55. Jackson LA, Campbell LA, Kuo CC, Rodriguez DI, Lee A, Grayston JT. Isolation of Chlamydia pneumoniae from a carotid endarterectomy specimen. J Infect Dis 1997;176:292-5